Palisade Asset Management’s Clorox CLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$406K Sell
4,250
-75
-2% -$7.2K 0.04% 170
2026
Q1
$448K Sell
4,325
-5
-0.1% -$567 0.05% 158
2025
Q4
$437K Sell
4,330
-1,785
-29% -$194K 0.04% 155
2025
Q3
$754K Sell
6,115
-515
-8% -$63.9K 0.07% 129
2025
Q2
$796K Sell
6,630
-1,180
-15% -$157K 0.08% 127
2025
Q1
$1.15M Sell
7,810
-50
-0.6% -$7.63K 0.12% 111
2024
Q4
$1.28M Sell
7,860
-90
-1% -$14.7K 0.13% 106
2024
Q3
$1.3M Sell
7,950
-5
-0.1% -$741 0.13% 107
2024
Q2
$1.09M Sell
7,955
-1,605
-17% -$223K 0.11% 113
2024
Q1
$1.46M Hold
9,560
0.14% 104
2023
Q4
$1.36M Sell
9,560
-590
-6% -$78.7K 0.15% 99
2023
Q3
$1.33M Buy
10,150
+370
+4% +$56.2K 0.16% 101
2023
Q2
$1.56M Hold
9,780
0.18% 96
2023
Q1
$1.55M Sell
9,780
-25
-0.3% -$3.75K 0.19% 96
2022
Q4
$1.38M Buy
9,805
+330
+3% +$46.8K 0.16% 105
2022
Q3
$1.22M Hold
9,475
0.17% 99
2022
Q2
$1.34M Buy
9,475
+45
+0.5% +$6.43K 0.17% 95
2022
Q1
$1.31M Buy
9,430
+1,245
+15% +$191K 0.15% 102
2021
Q4
$1.43M Sell
8,185
-375
-4% -$62.5K 0.16% 101
2021
Q3
$1.42M Buy
8,560
+785
+10% +$135K 0.17% 98
2021
Q2
$1.4M Buy
7,775
+1,080
+16% +$197K 0.16% 98
2021
Q1
$1.29M Buy
6,695
+75
+1% +$14.4K 0.17% 98
2020
Q4
$1.34M Buy
6,620
+1,445
+28% +$299K 0.18% 93
2020
Q3
$1.09M Sell
5,175
-80
-2% -$17.8K 0.16% 94
2020
Q2
$1.15M Sell
5,255
-30
-0.6% -$5.99K 0.18% 89
2020
Q1
$916K Hold
5,285
0.17% 93
2019
Q4
$811K Buy
5,285
+140
+3% +$20.9K 0.12% 113
2019
Q3
$781K Hold
5,145
0.12% 110
2019
Q2
$788K Sell
5,145
-35
-0.7% -$5.35K 0.12% 111
2019
Q1
$831K Buy
5,180
+95
+2% +$14.7K 0.13% 110
2018
Q4
$784K Sell
5,085
-370
-7% -$57.6K 0.12% 102
2018
Q3
$820K Hold
5,455
0.11% 104
2018
Q2
$738K Buy
5,455
+740
+16% +$91.3K 0.11% 106
2018
Q1
$628K Hold
4,715
0.09% 114
2017
Q4
$701K Sell
4,715
-125
-3% -$17K 0.11% 108
2017
Q3
$638K Sell
4,840
-220
-4% -$29.6K 0.12% 97
2017
Q2
$674K Hold
5,060
0.13% 89
2017
Q1
$682K Hold
5,060
0.13% 88
2016
Q4
$607K Hold
5,060
0.12% 95
2016
Q3
$633K Hold
5,060
0.12% 92
2016
Q2
$700K Sell
5,060
-200
-4% -$25.9K 0.13% 91
2016
Q1
$663K Hold
5,260
0.13% 91
2015
Q4
$667K Sell
5,260
-10
-0.2% -$1.24K 0.14% 89
2015
Q3
$609K Sell
5,270
-50
-0.9% -$5.61K 0.14% 94
2015
Q2
$553K Sell
5,320
-50
-0.9% -$5.39K 0.11% 98
2015
Q1
$593K Buy
5,370
+40
+0.8% +$4.34K 0.12% 98
2014
Q4
$555K Sell
5,330
-20
-0.4% -$2K 0.11% 96
2014
Q3
$514K Buy
5,350
+820
+18% +$74.2K 0.11% 95
2014
Q2
$414K Buy
4,530
+170
+4% +$15.2K 0.09% 102
2014
Q1
$384K Buy
4,360
+610
+16% +$53.6K 0.08% 104
2013
Q4
$348K Hold
3,750
0.08% 107
2013
Q3
$306K Sell
3,750
-1,740
-32% -$147K 0.08% 107
2013
Q2
$456K Buy
+5,490
New +$472K 0.11% 94

Other funds holding CLX

Palisade Asset Management's CLX Position: Q2 2026 in Review

Palisade Asset Management reduced its Clorox (CLX) stake by 1.7% in Q2 2026, selling an estimated $7.2K and leaving 4,250 shares worth $406K. The position accounts for 0.04% of the portfolio, ranked #170.

Palisade Asset Management first reported a position in CLX in Q2 2013 and has held it in 53 quarters since. The position peaked at $1.56M in Q2 2023. 1,041 funds tracked by Wall St. Rank hold CLX as of Q2 2026.

  • Palisade Asset Management held 4,250 shares of Clorox worth $406K as of Q2 2026.
  • Palisade Asset Management sold 75 Clorox shares in Q2 2026, an estimated $7.2K.
  • Clorox made up 0.04% of Palisade Asset Management's portfolio in Q2 2026, its #170 holding.
  • Palisade Asset Management first reported a position in Clorox in Q2 2013 and has held it in 53 quarters since.
  • Palisade Asset Management's Clorox position peaked at $1.56M in Q2 2023.
  • 1,041 funds tracked by Wall St. Rank held Clorox as of Q2 2026.

Based on Palisade Asset Management's 13F filing for Q2 2026, filed 20 Jul 2026.